Bristol-Myers Squibb Company(BMY) Q3
EPS: 1.35 USD; Forecast 1.1 USD
Revenue: 13.07B USD; Forecast 12.72B USD
Reporting period: 2026 Q3 (period ended 2026-09-30)
Release date: 2026-10-29